Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall A Lichtman

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
The Oncologist|October 9, 2010
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaMarshall A Lichtman
Blood Cells, Molecules & Diseases|August 14, 2016
The World Health Organization revisits the classification of the myelodysplastic syndromes: Improvement and insufficienciesMarshall A Lichtman
Rambam Maimonides Medical Journal|August 3, 2022
Controversies in Selecting Nobel Laureates: An Historical CommentaryMarshall A Lichtman
The Oncologist|August 19, 2021
Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of PathobiologyMarshall A Lichtman
Best Practice & Research. Clinical Haematology|December 5, 2009
Establishment of the Ernest Beutler Memorial LectureMarshall A Lichtman
Blood|October 6, 2007
Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesisMarshall A Lichtman
Blood|January 22, 2002
Language and the clonal myeloid diseasesMarshall A Lichtman
Blood Cells, Molecules & Diseases|November 17, 2012
A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3Marshall A Lichtman
Blood Cells, Molecules & Diseases|February 12, 2021
Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestionsMarshall A Lichtman
The Oncologist|February 29, 2008
Battling the hematological malignancies: the 200 years' warMarshall A Lichtman
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
The Oncologist|October 9, 2010
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaMarshall A Lichtman
Blood Cells, Molecules & Diseases|August 14, 2016
The World Health Organization revisits the classification of the myelodysplastic syndromes: Improvement and insufficienciesMarshall A Lichtman
Rambam Maimonides Medical Journal|August 3, 2022
Controversies in Selecting Nobel Laureates: An Historical CommentaryMarshall A Lichtman
The Oncologist|August 19, 2021
Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of PathobiologyMarshall A Lichtman
Best Practice & Research. Clinical Haematology|December 5, 2009
Establishment of the Ernest Beutler Memorial LectureMarshall A Lichtman
Blood|October 6, 2007
Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesisMarshall A Lichtman
Blood|January 22, 2002
Language and the clonal myeloid diseasesMarshall A Lichtman
Blood Cells, Molecules & Diseases|November 17, 2012
A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3Marshall A Lichtman
Blood Cells, Molecules & Diseases|February 12, 2021
Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestionsMarshall A Lichtman
The Oncologist|February 29, 2008
Battling the hematological malignancies: the 200 years' warMarshall A Lichtman
Pageof 6